Tag: Generative AI in pharma

Pharma R&D with Generative AI: Molecule Design and Trial Protocol Drafts

Generative AI is transforming pharma R&D by accelerating molecule design and streamlining trial protocol drafts. Discover how agentic AI and computational screening cut discovery timelines by 30-40%, though clinical success rates remain under scrutiny.

Guardrails and Filters: Stopping Harmful LLM Content

Oct, 5 2026
Risk and Controls for Generative AI: Policies, Approvals, and Monitoring Strategy

Mar, 29 2026
Playbooks for Rolling Back Problematic AI-Generated Deployments

Sep, 30 2026
Memory and State Management for Persistent LLM Agents

Sep, 17 2026
Preventing Catastrophic Forgetting During LLM Fine-Tuning: Techniques That Work

Feb, 12 2026

Tag: Generative AI in pharma

Pharma R&D with Generative AI: Molecule Design and Trial Protocol Drafts

Recent Post

Guardrails and Filters: Stopping Harmful LLM Content

Risk and Controls for Generative AI: Policies, Approvals, and Monitoring Strategy

Playbooks for Rolling Back Problematic AI-Generated Deployments

Memory and State Management for Persistent LLM Agents

Preventing Catastrophic Forgetting During LLM Fine-Tuning: Techniques That Work

Categories

Archives